Ipratropium Bromide

Locally administered (inhaled) ipratropium bromide is an antimuscarinic agent used for the adjunctive treatment of bronchospastic conditions, such as Recurrent Airway Obstruction (RAO) in horses and chronic respiratory diseases in small animals. **Clinical Pearls:** * Ipratropium is a quaternary ammonium derivative of atropine. Because of its highly polar nature, it is poorly absorbed into the systemic circulation and does not readily cross the blood-brain barrier, significantly reducing the risk of systemic anticholinergic side effects. * It has a relatively short duration of activity and may need to be administered frequently. * While there is limited formal pharmacokinetic data in small animals, it is generally considered safe and effective as an adjunctive bronchodilator.

กลไกการออกฤทธิ์: Ipratropium acts as a competitive antagonist of **acetylcholine** at muscarinic receptors in the bronchial smooth muscle. * **Mechanism:** Antagonizes acetylcholine → Prevents increases in intracellular **cyclic guanosine monophosphate (cGMP)** → Reduces bronchial smooth muscle constriction. * **Advantage over Atropine:** Unlike atropine, ipratropium **does not reduce mucociliary clearance**, making it highly beneficial for patients with respiratory diseases where clearing airway secretions is critical.

ข้อมูลอ้างอิงยาของ VetSheet มีไว้สำหรับสัตวแพทย์ผู้มีใบอนุญาตเพื่อช่วยในการตัดสินใจทางคลินิก ไม่ใช่สิ่งทดแทนการวินิจฉัยของผู้เชี่ยวชาญหรือฉลากล่าสุดของผู้ผลิต